Type-2 diabetes is one of the most common chronic diseases in the world, characterized by high blood-sugar levels and ...

Medical experts recognize type 5 diabetes as separate from other types, requiring specialized treatment focusing on ...

For years, the classic prescription for those at risk of diabetes has been simple: lose weight. But new research contradicts ...

Editor's note: Part one of a five-part USA TODAY series revealing why America hasn't solved its long struggle with Type 2 diabetes. For chef Robin Ray, newly married with young stepchildren, the ...

Henagliflozin, a diabetes treatment approved in China, may do more than just control blood sugar—it may actually slow ...

Diabetes affects 37 million people in the U.S. The Centers for Disease Control and Prevention estimates another 96 million people – or 1 in 3 adults – have prediabetes, a condition where blood sugar ...

Learn about type 5 diabetes, a newly recognized but long-known form linked to malnutrition, and how it differs from type 1 ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

Across the Arabian Peninsula, home to the Gulf Cooperation Council (GCC) states, societies have transformed within a century ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

A USC study finds that high blood pressure, diabetes, and low HDL cholesterol are the top killers in fatty liver disease ...

Experts say the condition—formally known as latent autoimmune diabetes in adults—can result in health complications if it isn’t diagnosed and treated properly.